Bixiye
QP11-21 Commercial Pharmacy Benefit Exclusion for Select Medications
Taariikhda uu dhaqangalayo Barnaamijka: 10, Feb 2021
Natiijooyinka Raadinta
Soo bandhiga 1761 - 1770 ee natiijooyinka 4229
Bixiye
QP10-21 Commercial Pharmacy Benefit Exclusion for Emtricitabine-Tenofovir Disoproxil Fumarate Tablet 100-150 mg, 133-200 mg, and 167-250 mg
Taariikhda uu dhaqangalayo Barnaamijka: 10, Feb 2021
Bixiye
QP12-21 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective April 1, 2021
Taariikhda uu dhaqangalayo Barnaamijka: 10, Feb 2021
Dukaamaysiga & Barashada
step-therapy-explained.pdf
Bixiye
P56-21 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective December 6, 2021
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2021
Bixiye
P55-21 Early Intensive Developmental and Behavioral Intervention (EIDBI) Service Authorization and Claims Submission for Minnesota Health Care Programs
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2021
Bixiye
P59-21 New: eviCore Home Health Care (HHC) Supplementary Guidelines for Medicare Advantage Subscribers
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2021
Bixiye
P57-21 2022 Renewal Changes Summary for Primary Care Clinic Providers
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2021